Centene Corporation (CNC)

NYSE: CNC · Real-Time Price · USD

59.37

-0.48 (-0.80%)

At close: May 01, 2025, 12:08 PM

-0.80% (1D)

Bid	59.35
Market Cap	29.54B
Revenue (ttm)	169.28B
Net Income (ttm)	3.45B
EPS (ttm)	6.78
PE Ratio (ttm)	8.76
Forward PE	7.41
Analyst	Buy

Ask	59.37
Volume	1,983,724
Avg. Volume (20D)	5,446,517.2
Open	59.48
Previous Close	59.85
Day's Range	58.49 - 60.14
52-Week Range	55.03 - 80.59
Beta	0.53

About CNC

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible i...

[Read more]

Industry Medical - Healthcare Plans

Sector Healthcare

IPO Date Dec 13, 2001

Employees 60,400

Stock Exchange NYSE

Ticker Symbol CNC

Website https://www.centene.com

Full Company Profile

Analyst Forecast

According to 14 analyst ratings, the average rating for CNC stock is "Buy." The 12-month stock price forecast is $84, which is an increase of 41.49% from the latest price.

Stock Forecasts

Earnings Surprise

Centene has released their quartely earnings on Apr 25, 2025:

Revenue of $46.62B exceeds estimates by $3.26B, with 15.38% YoY growth.

EPS of 2.9 exceeds estimates by 0.36, with 28.32% YoY growth.

Why Price Moved

5 days ago

-6.32%

Centene shares are trading lower after the company... Unlock content with Pro Subscription

1 week ago

-4.43%

Shares of health insurance stocks are trading lower in sympathy with UnitedHealth, which reported worse-than-expected Q1 results and cut its FY25 adjusted EPS guidance below estimates on Thursday.

News

Just now · zacks.com

Best Value Stocks to Buy for May 1st

CNC and FSFG made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 1, 2025.

Just now · zacks.com

New Strong Buy Stocks for May 1st

FIX, RITM, CCEP, CRS and CNC have been added to the Zacks Rank #1 (Strong Buy) List on May 1, 2025.

1 day ago · zacks.com

CNC vs. HUM: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - HMOs sector have probably already heard of Centene (CNC) and Humana (HUM). But which of these two stocks presents investors with the better value oppo...

18 hours ago · zacks.com

Boost Your Portfolio With These 5 Low Price-to-Book Stocks

The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, MD, PFE, STNE and SAN are some such stocks.

2 days ago · zacks.com

Earnings Season: 3 Companies Raising Guidance

Raising guidance? In this uncertainty?

2 days ago · zacks.com

Should Value Investors Buy Centene (CNC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

6 days ago · zacks.com

Centene Q1 Earnings Beat Estimates on Marketplace Business Strength

CNC's Q1 results benefit from improved premiums as a result of a strong PDP business, partly offset by elevated operating costs. It currently expects 2025 premium and service revenues within $164-$166...

6 days ago · seekingalpha.com

Centene Corporation (CNC) Q1 2025 Earnings Call Transcript

Centene Corporation (NYSE:CNC ) Q1 2025 Earnings Conference Call April 25, 2025 8:30 AM ET Company Participants Jennifer Gilligan - Senior Vice President, Finance and Investor Relations Sarah London -...

5 days ago · zacks.com

Centene (CNC) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates...

5 days ago · zacks.com

Centene (CNC) Beats Q1 Earnings and Revenue Estimates

Centene (CNC) came out with quarterly earnings of $2.90 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $2.26 per share a year ago.

Load More News